Capital Change Notice – Issue of Options

13 September 2023 Issue of Options This notice is given under NZX Listing Rule 3.13.1 and relates to unlisted Options to acquire ordinary shares in the Company ('Options') issued under the Fisher & Paykel Healthcare 2022 Share Option Plan ('Option Plan), the 2022 Sub-Plan for France ('Sub-Plan for France') and the Fisher & Paykel Healthcare 2022 Share Option Plan - North America ('North America Plan'). Section 1: Issuer information Name of issuer Fisher & Paykel Healthcare Corporation Limited NZX ticker code FPH Class of financial product Options issued under the Option Plan, the Sub-Plan for France and the North America Plan ISIN (If unknown, check on NZX website) NZFAPE0001S2 Currency NZD Section 2: Capital change details Number issued/acquired/redeemed 920,620 Nominal value (if any) Not applicable Issue/acquisition/redemption price per security No amount is payable for the grant of Options. The Options have an exercise price of $21.96 per share (being the volume weighted average price for a share on the NZX for the five business days prior to the grant date). Nature of the payment (for example, cash or other consideration) Not applicable Amount paid up (if not in full) Not applicable Percentage of total class of Financial Products issued/acquired/redeemed/ (calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence) 920,620 Options to acquire ordinary shares representing approximately 0.15825% of the ordinary shares on issue. For an issue of Convertible Financial Products or Options, the principal terms of Conversion (for example the Conversion price and Conversion date and the ranking of the Financial Product in relation to other Classes of Financial Product) or the Option (for example, the exercise price and exercise date) Not Applicable Reason for issue/acquisition/redemption and specific authority for issue/acquisition/redemption/ (the reason for change must be identified here) Issue of Options under the Option Plan, the Sub-Plan for France and the North America Plan to incentivise selected employees to grow the Company and to attract, motivate and retain key employees. Total number of Financial Products of the Class after the issue/acquisition/redemption/Conversion (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue/acquisition/redemption. 3,431,582 Options In the case of an acquisition of shares, whether those shares are to be held as treasury stock Not applicable Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue, acquisition, or redemption is made Directors' resolution dated 29 August 2023. Terms or details of the issue, acquisition, or redemption (for example: restrictions, escrow arrangements) The Options will be issued on the terms of the Option Plan, the Sub-Plan for France and the North America Plan, as approved by the Board. Date of issue/acquisition/redemption 12 September 2023 Section 3: Authority for this announcement and contact person Name of person authorised to make this announcement Raelene Leonard Contact person for this announcement Raelene Leonard Contact phone number +64 9 574 0147 Contact email address raelene.leonard@fphcare.co.nz Date of release through MAP 13 September 2023 End CA:00418160 For:FPH Type:SECISSUE Time:2023-09-13 15:40:50